Search Results - "Megalios, Anargyros"
-
1
Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
Published in Breast cancer research : BCR (06-05-2019)“…Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal breast cancer, and approximately 20% of screen-detected tumours are pure DCIS…”
Get full text
Journal Article -
2
MetaboCraft: building a Minecraft plugin for metabolomics
Published in Bioinformatics (01-08-2018)“…Abstract Motivation The rapid advances in metabolomics pose a significant challenge in presentation and interpretation of results. Development of new, engaging…”
Get full text
Journal Article -
3
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
Published in Nature genetics (01-06-2022)“…Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite treatment, a small fraction (5–10%) of DCIS patients develop…”
Get full text
Journal Article -
4
Abstract PS16-03: Clonal relatedness of LCIS with synchronous and asynchronous invasive disease
Published in Cancer research (Chicago, Ill.) (15-02-2021)“…Abstract Background: Lobular carcinoma in situ (LCIS) is typically clinically undetectable but is being increasingly diagnosed as a result of breast screening…”
Get full text
Journal Article -
5
Abstract P4-07-04: Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract In order to understand the clonal relatedness of DCIS and subsequent recurrence, 40 patients with primary DCIS that developed a subsequent ipsilateral…”
Get full text
Journal Article -
6
Abstract P4-06-05: Heterogeneity of DCIS does not appear to be a biomarker for development of subsequent invasive cancer
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Genomic instability is a key feature of carcinogenesis, giving rise to tumour promoting aberrations. The inherent unpredictability of these processes…”
Get full text
Journal Article -
7
Abstract P1-22-05: Identifying predictors of invasive recurrence based on molecular profiles of DCIS lesions
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract Introduction Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. Patients with DCIS are routinely treated by…”
Get full text
Journal Article -
8
Abstract PR002: Genomic predictor can discriminate between high- and low-risk DCIS
Published in Cancer prevention research (Philadelphia, Pa.) (01-12-2022)“…Abstract Introduction: Ductal carcinoma in situ (DCIS) is considered a non-obligate precursor of invasive ductal carcinoma. With the aim of preventing a…”
Get full text
Journal Article -
9
Abstract 6212: Multiomics analyses reveal multimodal Fusobacterium DNA damage perturbations in colorectal cancer
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Fusobacterium nucleatum is an opportunistic bacterial pathogen and oncogenic microbe. To systematically investigate Fusobacterium-host interactions in…”
Get full text
Journal Article -
10
Abstract 5108: Copy number analysis of pure DCIS and association with recurrence
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract With the widespread adoption of breast cancer screening the incidence of pure ductal carcinoma in situ (DCIS) has increased. As DCIS is considered a…”
Get full text
Journal Article